IRIDEX Corporation (IRIX) vs NeuroOne Medical Technologies Corporation (NMTC)

IRIDEX Corporation and NeuroOne Medical Technologies Corporation are both Medical Devices companies. IRIDEX Corporation and NeuroOne Medical Technologies Corporation are of similar size ($12.1M and $11.1M). IRIDEX Corporation grew revenue faster over the last twelve months: 3.68% against −1.67%. IRIDEX Corporation has the higher net margin (−6.88% vs −78.6%) and the higher return on invested capital (−63.1% vs −287.1%). Across the 17 metrics below, IRIDEX Corporation leads on 11 and NeuroOne Medical Technologies Corporation on 6.

Valuation

Metric IRIX NMTC Medical Devices median
P/E n/m n/m 22.18
P/S 0.21 1.22 2.70
P/B n/m 3.06 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.23 1.00 2.38
Earnings yield (31.75%) (67.67%) (8.22%)
Free cash flow yield (18.23%) (62.16%) (7.80%)

Profitability

Metric IRIX NMTC Medical Devices median
Gross margin 35.92% 55.65% 56.01%
Operating margin (5.39%) (83.43%) (15.03%)
Net margin (6.88%) (78.63%) (20.40%)
Free cash flow margin (3.88%) (75.63%) (7.24%)
Return on equity 308.17% (124.66%) (15.32%)
Return on assets (12.06%) (87.56%) (19.72%)
Return on invested capital (63.07%) (287.08%) (10.33%)

Growth

Metric IRIX NMTC Medical Devices median
Revenue growth (TTM) 3.68% (1.67%) 8.80%
EPS growth (last fiscal year) 51.85% 80.43% —
Revenue growth, 5-year CAGR 7.70% 44.41% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRIX NMTC Medical Devices median
Debt to equity 1.04 0.00 0.07
Current ratio 1.82 2.84 2.50
Net debt to EBITDA 2.68 1.74 0.49

Dividend

Metric IRIX NMTC Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric IRIX NMTC Medical Devices median
Market cap 11.07m 12.11m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack